SanaClis announces the rescheduling of the XV Interdisciplinary Drug Development Expert Workshop

6th November 2020


“SanaClis, whilst active in its role of responding to the COVID-19 pandemic, a decision was taken to postpone our highly anticipated and invitation-only based XV Interdisciplinary Drug Development Expert Workshop” (XV. Expertengespräch), in Frankfurt am Main, Germany, on 15 May 2020. COVID-19 continues to impact all people, across all industries and it is therefore imperative that the clinical industry continues to thrive and develop, thus limiting the impact on all on-going or planned drug development programs.

As a result, SanaClis is delighted to announce, that the XV Interdisciplinary Drug Development Expert Workshop shall now go ahead on Friday 6th November 2020, Frankfurt am Main, Germany. We look forward to welcoming our exceedingly regarded and high calibre colleagues from across the industry to the event, providing a platform to share thought provoking strategies, debate key and current issues thereby ensuring that innovative research continues to flourish despite such times of unprecedented uncertainty and global challenge. The impressive array of topics and speakers are contained in the agenda herewith attached. To register your interest to attend, please note and send your interest to info-germany@sanaclis.eu .”

Erfolgreiche Arzneimittelentwicklung unter Kostenzwängen und Regelungsdichte